Laboratory

Discover our products

Clinical

Discovers our solutions

Immediate Availability of New DeepChek Assays for HIV-1 V3/Tropism Determination and Viral Hepatitis B Genotyping

Jul 10, 2017

ABL is pleased to announce the immediate available of two new DeepChek® Assays intended to be used for: Determining eligibility for CCR5 antagonist treatment in patients infected with human immunodeficiency virus 1 (HIV-1) – DeepChek®-HIV V3 Loop/Tropism Assay HBV genotyping, drug resistance a…
Read more
Advanced Biological Laboratories and Right to Care collaborate to strengthen HIV treatment

Jul 04, 2017

Advanced Biological Laboratories S.A. and Right to Care enter into an exclusive distribution and development collaboration (open source) agreement covering EQUIP in 17 developing countries to strengthen HIV (and other infectious disease) treatment and prevention. Johannesburg (South Africa), Boston…
Read more
Competitors and suppliers collaborate in the interests of advancing health technology

Jul 04, 2017

South Africa/Luxembourg, Tuesday, 4 July 2017: The Foundation for Professional Development (FPD) Group and Right to Care Group, joined forces to bring their healthcare technology under one umbrella for the advancement of health outcomes in developing countries. The new organisation which will house…
Read more

ABL Announces Distribution Agreement with Kron Científica e Industrial S.A. in Guatemala

Jun 27, 2017

Advanced Biological Laboratories (ABL) S.A. and Kron Científica e Industrial S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Guatemala. See current channel partners.
Read more
2 nouveaux établissements équipés avec CeGInaDis

Jun 16, 2017

Fédialis Médica a le plaisir de vous informer que les hôpitaux de la Pitié-Salpêtrière à Paris, ainsi que le CHU de Fort de France en Martinique utilisent notre logiciel CeGInaDis (version CeGIDD du logiciel NADIS) pour leurs activités de routine CeGIDD.
Read more
ABL Announces Distribution Agreement with BADER SULTAN & BROTHERS CO W.L.L

Jun 09, 2017

Advanced Biological Laboratories (ABL) S.A. and BADER SULTAN & BROTHERS CO W.L.L are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Kuwait. See current channel partners.
Read more

In June Save Up to 20% on all DeepChek® Assays for HIV and HCV

May 31, 2017

I’m interested!
Read more
Annonce d’un nouveau partenariat AFRAVIH – Fédialis Médica

May 23, 2017

Fédialis Médica a le plaisir de vous informer de la signature d’un partenariat avec l’AFRAVIH (www.afravih.org/) dans le but de tester l’utilisation du dossier médical informatisé NADIS pour le suivi et la prise en charge de patients vivant avec une pathologie chronique (VIH, hépatite, t…
Read more
SEQHEPB V6 – The Largest HBV Interpretation System & Database

May 17, 2017

ABL is pleased to announce the official release of its SeqHepB v6 interpretation system & database. Dedicated to the management of Viral Hepatitis B (HBV) sequencing data, the software can handle Capillary Electrophoresis or Next Generation Sequencing data, performs genotyping and mutation detec…
Read more